ARCHIVES

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Komen Foundation Breast Cancer Awards

April 15, 1994

FDA Discloses Avastin Regulatory History.

December 14, 2007

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994